StockNews.com’s investment analysts have started reporting on the stock. Neptune Wellness Solutions (NASDAQ:NEPT – Get Free Report) (TSE:NTB) said in a research note published on Sunday. The firm has assigned a “sell” rating to the biotechnology company’s stock.
Neptune Wellness Solutions Stock Performance
Neptune Wellness Solutions has a 52-week low of $0.19 and a 52-week high of $28.00. The stock’s 50-day moving average is $0.43 and its 200-day moving average is $3.35. The company has a market capitalization of $906,000.00, a price-to-earnings ratio of 0.00 and a beta of 2.19.
Insiders place bets
In other news, major shareholder, Securities Settlement Neptune sold 64,819 shares of the company’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $0.44, for a total value of $28,520.36. Following the transaction, the insider now owns 1,738,116 shares of the company’s stock, valued at approximately $764,771.04. The sale was disclosed in a legal filing with the Securities and Exchange Commission, which can be accessed on the SEC’s website. Insiders own 5.10% of the company’s shares.
Inflow and outflow of institutions
Several hedge funds have recently made changes to their holdings in the business. Renaissance Technologies LLC increased his holdings in shares of Neptune Wellness Solutions by 12.6% in the 3rd quarter. Renaissance Technologies LLC now owns 128,684 shares of the biotechnology company’s stock valued at $196,000 after purchasing an additional 14,395 shares during the last quarter. Citadel Advisors LLC bought a new position in shares of Neptune Wellness Solutions during the 3rd quarter valued at approximately $43,000. Stifel Financial Corp bought a new position in shares of Neptune Wellness Solutions in the 1st quarter valued at approximately $41,000. Virtu Financial LLC increased its holdings in shares of Neptune Wellness Solutions by 257.6% in the 1st quarter. Virtu Financial LLC now owns 554,376 shares of the biotechnology company’s stock valued at $123,000 after purchasing an additional 399,362 shares during the last quarter. Finally, Morgan Stanley increased its holdings in shares of Neptune Wellness Solutions by 26,898.7% in the 4th quarter. Morgan Stanley now owns 544,833 shares of the company’s stock valued at $172,000 after purchasing an additional 542,815 shares during the last quarter. Institutional investors own 14.44% of the company’s stock.
About Neptune Wellness Solutions
(Get Free Report)
Neptune Wellness Solutions Inc is a health and wellness products company that specializes in the extraction, purification and formulation of cannabis products as well as other specialty ingredients such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutritional supplements. Masu. Other marine and seed oils.
Related item
Receive daily Neptune Wellness Solutions news and reviews – Enter your email address below to receive a concise, daily summary of the latest news and analyst ratings for Neptune Wellness Solutions and related companies in MarketBeat.com’s free daily email newsletter.
